Table 1. Encyclopedic tumor analysis (ETA) findings.
Sample Type Received | Gene Name | Molecular alteration |
---|---|---|
(left supraclavicular node biopsy) | TP53 p. C141R | SNV (32% MAF) |
TP53 p. R158C | SNV (2.2% MAF) | |
CDKN2A p. G122D | SNV (2.9% MAF) | |
ABL1 p. T315I | SNV (2.1% MAF) | |
SYNE1 p. K7182fs*17 | SNV (4.6% MAF) | |
CDK12, PGAP3, ERBB2 (17q12 - 17q12) | CNV (18 gain) | |
CCNE1 (19q12 - 19q12) | CNV (14 gain) | |
AR (IHC) | Negative | |
Blood | Chemo-sensitivity on C-TACs | Cyclophosphamide 38% and Methotrexate 44% CD |
MAF – Mutant allele frequency; SNV – Single nucleotide variation; CNV – copy number variation; DGE – Differential gene expression; C-TACs – Circulating Tumor Associated cells; CD – Cell death.